M

Moderna

Develops mRNA-based medicines for health

Vice President, Therapeutics Immunology

Translational Research & Bench BiologyConfirmed live in the last 24 hours
Full-timeCambridge, MA, USA

About the Job

Requirements

  • A PhD, MD, or MD/PhD in immunology, cell biology, molecular biology, or a related discipline, with deep training in T cell immunology.
  • At least 15 years of relevant post-terminal-degree experience in biotechnology, pharmaceutical research, or an equivalent translational research setting, including at least 5 years leading multidisciplinary scientific teams and leaders.
  • Internationally recognized expertise in human T cell biology, including TCR peptide-MHC biology, antigen-specific Treg responses, immune tolerance, and mechanisms of autoimmune disease.
  • A record of advancing therapeutic programs from discovery through development candidate nomination and preclinical development; experience supporting an IND or early clinical development is required.
  • Demonstrated ability to build or scale a discovery platform, functional area, or research organization and convert platform capabilities into a portfolio of therapeutic programs.
  • Expertise in TCR discovery, repertoire analysis, antigen-specific T cell identification, functional screening, and experimental and computational approaches used to assess TCR specificity and cross-reactivity.
  • Strong working knowledge of therapeutic protein or receptor engineering, developability, in vitro and in vivo pharmacology, translational biomarkers, and nonclinical safety considerations.
  • Substantial experience in autoimmune or inflammatory disease research, including use of human data and disease-relevant models to prioritize targets and evaluate mechanism.
  • A record of influential scientific contributions demonstrated through therapeutic programs, publications, patents, invited presentations, or implementation of important discovery technologies.
  • Ability to translate complex science into clear strategic choices, make portfolio decisions under uncertainty, and align scientific teams, senior executives, and external partners.
  • Experience developing TCR-based therapeutics, including one or more of TCR-T, soluble TCRs, TCR engagers, TCR-directed antibodies, or in vivo immune-cell reprogramming.
  • Experience building integrated workflows across single-cell profiling, TCR sequencing, peptide-MHC technologies, functional assays, display-based engineering, biophysical characterization, and computational protein design.
  • Experience with tolerance biology, pathogenic T cell depletion or modulation, regulatory T cell approaches, immune reset strategies, or related mechanisms in autoimmune disease.
  • Experience using high-dimensional human datasets and AI or machine-learning approaches to improve target selection, molecular design, or patient stratification.
  • Experience contributing to regulatory interactions and clinical development decisions for immune-modulating therapeutics.

Responsibilities

  • Set and execute the scientific strategy for the mRNA therapeutics immunology pipeline, establishing priorities across autoimmune disease, TCR-based medicines, and immune-modulating therapeutics.
  • Oversee internal TCR capabilities, including TCR deconvolution and an end-to-end TCR discovery and engineering engine to generate therapeutic TCRs at scale.
  • Lead the autoimmune research portfolio from concept ideation and target and disease hypothesis through lead generation, candidate selection, pharmacology, translational strategy, and preclinical development.
  • Establish decision criteria for efficacy, selectivity, cross-reactivity, developability, manufacturability, and translational relevance across immune-mediated mRNA modalities, including T cell engagers and in vivo cell therapy.
  • Translate insights from patient samples, single-cell and immune-repertoire data, human genetics, functional genomics, and disease models into therapeutic concepts.
  • Partner with mRNA science, lipid nanoparticle delivery, protein engineering, structural biology, computational biology, and AI teams to design medicines using Moderna's technology platform.
  • Partner with Clinical Development to shape mechanism-based development plans, biomarker and patient-selection strategies, clinical pharmacology hypotheses, proof-of-mechanism studies, and interpretation of clinical data.
  • Represent therapeutics immunology and autoimmune programs in senior cross-functional forums and integrate priorities with enterprise portfolio decisions; present recommendations, identify scientific and execution risks, and make evidence-based portfolio and resource decisions.
  • Lead the Therapeutics Immunology organization through senior scientific and functional leaders; set expectations, recruit, develop, and retain a multidisciplinary team; and establish succession and development plans.
  • Represent Moderna externally for Therapeutics Immunology and establish and lead collaborations with academic investigators, biotech and pharmaceutical companies, contract research organizations, and technology providers.
  • Evaluate partnership and licensing opportunities that accelerate the strategy.
  • Maintain an external scientific presence through publications, conferences, advisory relationships, and engagement with immunology leaders.
  • Establish and manage the function's budget, headcount, technology investments, and portfolio commitments in alignment with Research priorities.

About the Company

Moderna

Develops mRNA-based medicines for health

Moderna develops medicines built on messenger RNA (mRNA). Its products use mRNA delivered into cells to instruct them to produce specific proteins that can prevent or treat disease, with vaccines being a primary example. In practice, a dose delivers engineered mRNA into the body, cells translate it into a target protein, and the immune system responds or the protein modulates biology to combat disease. Moderna differentiates itself through its focus on building a whole mRNA medicines platform and in-house capabilities for designing, manufacturing, and scaling mRNA therapies, including rapid development and large-scale production. Its goal is to create a new category of medicines based on mRNA that can improve how diseases are discovered, developed, and treated, ultimately improving patient outcomes.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2010

Recently Posted Jobs

Explore more opportunities at Moderna

See more jobs